Clinical Trial Update: Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating bupivacaine liposomal injectable suspension for pain and narcotic use after elective orthognathic surgery has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthognathic Surgery

Drugs mentioned

• Bupivacaine Liposomal Injectable Suspension (bupivacaine liposomal injectable suspension)

Snippet

Sponsor: Boston University | Conditions: Orthognathic Surgery | Phase 4 | Status: WITHDRAWN